906 related articles for article (PubMed ID: 18646309)
1. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
Ivanov S
Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
[TBL] [Abstract][Full Text] [Related]
2. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
3. Vaginal dysplastic lesions in women with hysterectomy and receiving radiotherapy are linked to high-risk human papillomavirus.
Barzon L; Pizzighella S; Corti L; Mengoli C; Palù G
J Med Virol; 2002 Jul; 67(3):401-5. PubMed ID: 12116034
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus testing for primary screening of cervical cancer precursors.
Ratnam S; Franco EL; Ferenczy A
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):945-51. PubMed ID: 11008913
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening in the early post vaccine era.
Waxman AG
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
[TBL] [Abstract][Full Text] [Related]
6. [Status of screening tests for cervical cancer and its precancerous lesion].
Zhao FH; Rong SD; Qiao YL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):638-41. PubMed ID: 12901114
[TBL] [Abstract][Full Text] [Related]
7. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
Cibas ES; Hong X; Crum CP; Feldman S
Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
[TBL] [Abstract][Full Text] [Related]
8. Translational approaches to improving cervical screening.
Baldwin P; Laskey R; Coleman N
Nat Rev Cancer; 2003 Mar; 3(3):217-26. PubMed ID: 12612656
[TBL] [Abstract][Full Text] [Related]
9. Screening for cervical cancer with the human papillomavirus test in an area of central Italy with no previous active cytological screening programme.
Confortini M; Giorgi Rossi P; Barbarino P; Passarelli AM; Orzella L; Tufi MC
J Med Screen; 2010; 17(2):79-86. PubMed ID: 20660436
[TBL] [Abstract][Full Text] [Related]
10. A comparison of simultaneous cervical cytology, HPV testing, and colposcopy.
Hockstad RL
Fam Pract Res J; 1992 Mar; 12(1):53-60. PubMed ID: 1312758
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
[TBL] [Abstract][Full Text] [Related]
13. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up.
Frega A; Lukic A; Nobili F; Palazzo A; Iacovelli R; French D; Moscarini M
Anticancer Res; 2007; 27(6C):4491-4. PubMed ID: 18214065
[TBL] [Abstract][Full Text] [Related]
14. Comparison of visual inspection of cervix and Pap smear for cervical cancer screening.
Tayyeb R; Khawaja NP; Malik N
J Coll Physicians Surg Pak; 2003 Apr; 13(4):201-3. PubMed ID: 12718787
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus testing for primary cervical cancer screening.
Grce M; Davies P
Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
[TBL] [Abstract][Full Text] [Related]
16. [Integrating HPV testing for primary screening?].
Riethmuller D; Ramanah R; Pretet JL; Mougin C
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
[TBL] [Abstract][Full Text] [Related]
17. Role of human papilloma virus testing in cervical cancer prevention.
Fey MC; Beal MW
J Midwifery Womens Health; 2004; 49(1):4-13. PubMed ID: 14710135
[TBL] [Abstract][Full Text] [Related]
18. Cost of screening for cancerous and precancerous lesions of the cervix.
Méréa E; Le Galès C; Cochand-Priollet B; Cartier I; de Crémoux P; Vacher-Lavenu MC; Vielh P; Coste J
Diagn Cytopathol; 2002 Oct; 27(4):251-7. PubMed ID: 12357505
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
Wright TC
Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer screening programs in low-income communities. Experiences from Ecuador. Low cost detection of HPV infection in a developing country.
Cecchini G; Paganini G; D'Amico M; Cannone M; Bertuletti C; Barberis MC
Pathologica; 2009 Apr; 101(2):76-9. PubMed ID: 19886552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
